LIGAND PHARMACEUTICALS INC — Investor Relations & Filings
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company that functions as a capital and technology partner to the life sciences industry. The company's business model focuses on acquiring and developing royalty-generating assets by investing in the clinical development and commercialization of medicines. It manages a large, diverse portfolio of economic rights to partnered programs across therapeutic areas such as oncology, kidney disease, diabetes, and rare conditions. In addition to its royalty business, Ligand develops and licenses its proprietary technology platforms to a global network of biopharmaceutical partners. Its key technologies include Captisol®, a chemically modified cyclodextrin used to improve the solubility and stability of active pharmaceutical ingredients, and the NITRICIL™ platform.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| DEFA14A | 2026-05-18 | English | |
| 8-K | 2026-05-18 | English | |
| 10-Q | 2026-05-08 | English | |
| 8-K - LIGAND PHARMACEUTICALS INC (0000886163) (Filer) | 2026-05-07 | English | |
| Major Shareholding Notification 2026 | 2026-05-01 | English | |
| Major Shareholding Notification 2026 | 2026-05-01 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46385520 | DEFA14A | 2026-05-18 | English | ||
| 46385526 | 8-K | 2026-05-18 | English | ||
| 46155763 | 10-Q | 2026-05-08 | English | ||
| 42834703 | 8-K - LIGAND PHARMACEUTICALS INC (0000886163) (Filer) | 2026-05-07 | English | ||
| 46155787 | Major Shareholding Notification 2026 | 2026-05-01 | English | ||
| 46155789 | Major Shareholding Notification 2026 | 2026-05-01 | English | ||
| 46155782 | 8-K | 2026-04-30 | English | ||
| 46155792 | DEFA14A | 2026-04-27 | English | ||
| 37461463 | 8-K - LIGAND PHARMACEUTICALS INC (0000886163) (Filer) | 2026-04-27 | English | ||
| 46155795 | ARS | 2026-04-21 | English | ||
| 46155796 | DEFA14A | 2026-04-21 | English | ||
| 34907767 | DEF 14A - LIGAND PHARMACEUTICALS INC (0000886163) (Filer) | 2026-04-21 | English | ||
| 33067636 | 4 - LIGAND PHARMACEUTICALS INC (0000886163) (Issuer) | 2026-03-28 | English | ||
| 33067397 | 4 - LIGAND PHARMACEUTICALS INC (0000886163) (Issuer) | 2026-03-28 | English | ||
| 33067331 | 4 - LIGAND PHARMACEUTICALS INC (0000886163) (Issuer) | 2026-03-28 | English | ||
Market data
Market data not available
Price history
Peer group · Other financial service activities n.e.c., except insurance and pension funding activities
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Hero Innovation Group Inc.
FinTech developing digital financial and secure payment sol…
|
HRO | CA | Financial and insurance activit… |
|
Hi-Klass Trading and Investment Limited
Specializes in commercial goods trading and strategic inves…
|
542332 | IN | Financial and insurance activit… |
|
HIND COMMERCE LIMITED
Engaged in investment activities and wholesale trading of t…
|
538652 | IN | Financial and insurance activit… |
|
Hirose Tusyo Inc.
A financial services firm specializing in online foreign ex…
|
7185 | JP | Financial and insurance activit… |
|
HMCIB No.6 Special Purpose Acquisition Company Corp.
A special purpose acquisition company targeting businesses …
|
462020 | KR | Financial and insurance activit… |
|
Honey Payment Group Spolka Akcyjna
A financial technology company specializing in payment solu…
|
HPG | PL | Financial and insurance activit… |
|
Hongta Securities Co.,Ltd.
Provides securities brokerage, investment banking, and asse…
|
601236 | CN | Financial and insurance activit… |
|
Hoshi Resource Corporation
Non-operating Capital Pool Company seeking to acquire a bus…
|
HRC.P | CA | Financial and insurance activit… |
|
HOULIHAN LOKEY, INC.
Global investment bank providing M&A, restructuring, and fi…
|
HLI | US | Financial and insurance activit… |
|
Huaan Securities Co.,Ltd.
Provides securities brokerage, investment banking, and asse…
|
600909 | CN | Financial and insurance activit… |
LIGAND PHARMACEUTICALS INC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31289/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31289 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31289 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31289 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31289}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for LIGAND PHARMACEUTICALS INC (id: 31289)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.